Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of Mechanical Stapler for Aortic Anastomoses
This study is ongoing, but not recruiting participants.
First Received: April 27, 2006   Last Updated: October 8, 2006   History of Changes
Sponsored by: SVSE 2000 Ltd.
Information provided by: SVSE 2000 Ltd.
ClinicalTrials.gov Identifier: NCT00319475
  Purpose

Demonstrate the safety and performance of the Aortic Stapler when used to attach a synthetic graft to an aorta in AAA and Leriche Syndrome patients


Condition Intervention
Aortic Aneurysm, Abdominal
Leriche Syndrome
Procedure: AAA or AF/IB (end-to-end) in patients with Leriche Syndrome

MedlinePlus related topics: Aneurysms Aortic Aneurysm
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Official Title: Evaluation of Mechanical Stapler for Aortic Anastomoses

Further study details as provided by SVSE 2000 Ltd.:

Primary Outcome Measures:
  • Time to complete each stapled anastomosis.

Secondary Outcome Measures:
  • Post-operative follow up:
  • no leakage
  • no dilatation
  • no fistula or hematoma at the anastomotic sites

Estimated Enrollment: 10
Study Start Date: February 2006
Estimated Study Completion Date: July 2006
  Eligibility

Ages Eligible for Study:   21 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patient age is between 21 to 85 years old.
  • Patient is diagnosed with Abdominal Aortic Aneurysm (AAA) or -aorto-Iliac/Femoral Occlusive Arterial Disease (Leriche' syndrome) by CT-Angio examination and/or angiography examination in patients with Leriche' syndrome.
  • Patient with an aneurysm at the neck of the proximal or distal site that is between 5 to 10 mm and with a diameter of 16-22 mm.
  • Patient is scheduled for AAA repair

Exclusion Criteria:

  • Pregnant women
  • Active malignancy
  • Ruptured aneurysm
  • Thoraco-AAA
  • Patient with at least one of the following unstable risk factors:
  • Renal disease (Cr >2)
  • Ischemic heart disease (unstable Angina)
  • Obstructive Pulmonary Disease (contraindicated for open aortic surgery by respiratory function exam)
  • Severe CHF (EF < 25%)
  • Patient with known allergy to metals or to the contrast media
  • Participation in current or recent (within 60 days prior to surgery) clinical trial
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00319475

Locations
Germany
Augusta Hospital
Duesseldorf, Germany, 40472
Sponsors and Collaborators
SVSE 2000 Ltd.
Investigators
Principal Investigator: Ralf Kolvenbach, MD Augusta Hospital, Berlin
  More Information

No publications provided

Study ID Numbers: EU-DE 006
Study First Received: April 27, 2006
Last Updated: October 8, 2006
ClinicalTrials.gov Identifier: NCT00319475     History of Changes
Health Authority: Germany: Federal Institute for Drugs and Medical Devices

Study placed in the following topic categories:
Arterial Occlusive Diseases
Aortic Diseases
Aneurysm
Aortic Aneurysm, Abdominal
Vascular Diseases
Leriche Syndrome
Aortic Aneurysm
Abdominal Aortic Aneurysm

Additional relevant MeSH terms:
Arterial Occlusive Diseases
Pathologic Processes
Disease
Aortic Diseases
Aneurysm
Aortic Aneurysm, Abdominal
Syndrome
Vascular Diseases
Leriche Syndrome
Cardiovascular Diseases
Aortic Aneurysm

ClinicalTrials.gov processed this record on May 06, 2009